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Abstract
Background: It has been estimated that more than 1 million workers in the United States are
exposed to cobalt. Occupational exposure to 59 Co occurs mainly via inhalation and leads to various
lung diseases. Cobalt is classified by the IARC as a possible human carcinogen (group 2B). Although
there is evidence for in vivo and in vitro toxicity, the mechanisms of cobalt-induced lung toxicity
are not fully known. The purpose of this work was to identify potential signatures of acute cobalt
exposure using a toxicogenomic approach. Data analysis focused on some cellular processes and
protein targets that are thought to be relevant for carcinogenesis, transport and biomarker
research.
Results: A time course transcriptome analysis was performed on A549 human pulmonary cells,
leading to the identification of 85 genes which are repressed or induced in response to soluble 59
Co. A group of 29 of these genes, representing the main biological functions, was assessed by
quantitative RT-PCR. The expression profiles of six of them were then tested by quantitative RT-
PCR in a time-dependent manner and three modulations were confirmed by Western blotting. The
85 modulated genes include potential cobalt carriers (FBXL2, ZNT1, SLC12A5), tumor suppressors
or transcription factors (MAZ, DLG1, MYC, AXL) and genes linked to the stress response (UBC,
HSPCB, BNIP3L). We also identified nine genes coding for secreted proteins as candidates for
biomarker research. Of those, TIMP2 was found to be down-regulated and this modulation was
confirmed, in a dose-dependent manner, at protein level in the supernatant of exposed cells.
Conclusion: Most of these genes have never been described as related to cobalt stress and
provide original hypotheses for further study of the effects of this metal ion on human lung
epithelial cells. A putative biomarker of cobalt toxicity was identified.
Background
In the United States, more than a million workers are
potentially exposed to cobalt or its compounds [1].
Cobalt is massively used in the steel industry, being a
major constituent of hard metal alloys, in combination
with tungsten carbides. Other industrial uses include dia-
mond polishing with Co-containing disks and the pro-
duction of drying agents, pigments, and catalysts [2].
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Radioactive isotopes of cobalt are used in industry, medi-
cine and nuclear research. In nuclear power plants, 59Co-
containing alloys can be activated into radioactive 60Co
oxides, dispersed in the cooling water and then contami-
nate workers [3,4]. A study measuring the ambient air in
cobalt powder production reported concentrations of
cobalt ranging from 0.675 to 10 mg/m3 [5]. Airborne
concentrations measured in the working environment
from a factory producing hard-metal inserts ranged from
14.6 to 37.4 mg/m3 [6]. Occupational exposure to Co
occurs mainly via inhalation leading to various lung dis-
eases, such as pneumonitis, fibrosis and asthma [7,8]. As
with human exposure, animal exposure to cobalt-contain-
ing aerosols causes pronounced respiratory effects. A sin-
gle 30-minute exposure of rats to relatively high levels
(26–236 mg cobalt hydrocarbonyl/m3), resulted in lung
congestion, oedema, and haemorrhage [9]. Necrosis and
inflammation of the respiratory tract epithelium were
reported in rats exposed to 19 mg cobalt/m3 and mice
exposed to 1.9 mg cobalt sulfate/m3 over 16 days [10,11].
Some acute effects have been observed concerning general
public exposure. Lethal cardiomyopathy was reported in
people who consumed large quantities of beer containing
cobalt as a foam stabilizer (0.04–0.14 mg cobalt/kg/day),
and acute mortality accounted for 18% of the deaths [12].
A 19-month-old boy who swallowed an unknown
amount of cobalt chloride solution died 6.5 hours after
ingestion [13].
Following absorbtion by inhalation, cobalt is eliminated
in the urine. Biological monitoring of accidental exposure
mainly involves measuring the concentration of metal in
the urine. This might be inadequate for several reasons.
Firstly, the quantity of metal excreted (exposure marker)
does not necessarily reflect organ damage, which varies
from one person to another. Secondly, depending on the
chemical form, excretion does not necessarily reflect the
level of metal in the body because some forms are
retained in the lungs. Thirdly, depending on its solubility,
clearance can be very rapid and the cobalt may have left
the body by the time samples can be taken. Therefore, a
key issue in monitoring occupational exposure is the
availability of adequate biomarkers.
Although the chemical toxicity of cobalt has been proven,
the molecular mechanisms of its toxicity are not all
known. Cobalt is genotoxic [14,15], and an oxidizing
stress inducer [16]. It also induces apoptosis [17]. Cobalt
is used as a hypoxia-simulating agent [18], leading to
increased apoptosis, glycolysis, angiogenesis and erythro-
poiesis[19].
Since the lung is the main target organ of cobalt toxicity,
the human A549 lung cell line was chosen as a model for
this study, to evaluate cobalt toxicity. Noteworthy, this
cell line has been widely documented in molecular toxi-
cology, including hypoxia mimicked by cobalt [16,20].
Microarrays are currently used for large scale gene profil-
ing, measuring sensitive cell changes in response to xeno-
biotic exposure. Such investigative studies may help
identify new molecular targets for toxicants or provide
new hypotheses about their mechanisms of action [21].
We used toxicogenomic tools to detect biomolecular tar-
gets of acute cobalt exposure and identify candidates as
biomarkers of cobalt toxicity.
Results and discussion
Cobalt cytotoxicity
A549 is a stable tumor cell line, obtained from human
lung carcinoma, with properties of type II alveolar epithe-
lial cells [22]. The response of A549 cells to increasing
concentrations of cobalt (CoCl2) after 24 h exposure was
first analysed using the intracellular ATP measurement
that reflects early metabolic modification [23]. We deter-
mined that the concentration needed to decrease ATP con-
centration to 50% was reached at 2 mM cobalt (figure 1).
At this concentration, we measured an average load of 2.4
pg of cobalt per cell, using flame atomic absorption spec-
troscopy (data not shown). Some toxicologists, including
one reviewer of this paper, assume that cytotoxic doses are
too high to study specific cellular response to a toxicant
[31]. The consequence, on gene modulation, could be the
activation of large numbers of nonspecific pathways of
toxicity, particularly a predominance of apoptosis and
stress related genes. However, as the purpose of this study
was to simulate accidental acute exposure, we nevertheless
chose to expose A549 cells to an acute dose of cobalt (2
mM).
Differential gene expression and functional classification
The global transcriptional response was monitored using
CEA microarrays (GPL4263) [24]. A549 cells were treated
with 2 mM cobalt in a time course experiment. For each
experiment, control cells were grown in parallel and col-
lected simultaneously. At 30 min. and 2 h, six microarrays
(three dyeswaps) were hybridized with RNA from two dif-
ferent cell exposures. At 4 h, four microarrays (two dye-
swaps) were hybridized with RNA from two exposures
and at 24 h, 14 microarrays (seven dyeswaps) were
hybridized with RNA from three cell exposures. Details of
the experimental design and microarray data were submit-
ted to the Gene Expression Omnibus repository at the
National Center for Biotechnology Information [24] and
are accessible via number GSE5892. Data analysis was
performed as described in the methods section. After
applying our selection criteria to the data (ratio > 1.5 and
p < 0.05), we obtained a list of 173 modulated clones cor-
responding to 85 known genes. The modulation trend
was up-regulation since 53 genes were up-regulated andBMC Genomics 2007, 8:147 http://www.biomedcentral.com/1471-2164/8/147
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32 were down-regulated (table 1 and 2). The results
showed that the main effect was obtained after 24 h of
cobalt treatment (50 genes), and to a lesser extent after 30
min (16 genes). At 2 h and 4 h, 11 and 8 genes respectively
were found to be modulated. Since 24 h was the main cat-
egory in terms of modulated gene numbers, we reinforced
the study for this time point by performing a total of 14
microarrays.
We used DAVID [25] web-accessible software, to obtain
information from the Gene Ontology Database. We then
sorted the modulated genes manually into 8 major func-
tional classes (table 1 and 2), combining information
from DAVID, SWISS-PROT and additional elements taken
from the literature. The classifications of genes modulated
after 30 min and 24 h of cobalt treatment were compared.
At 30 min, the main category regulated was signal trans-
duction and trafficking (38%) and half of the modulated
genes coded for membrane proteins. This suggests strong
involvement of membrane transport in the early response
to cobalt exposure. The later response (24 h) mainly con-
cerned protein expression and turnover (34%), metabo-
lism and energy (20%), and finally signal transduction
and trafficking (16%). This different pattern indicates that
after 24 h, the cell response is established, with metabolic
adaptation and strong involvement of protein translation.
It can be noticed that in spite of the cytotoxic dose we
used, the genes modulation trend was rather increase than
decrease, indicating an active metabolic response of the
cell, and also that apoptotic and stress related genes are
not over represented.
Quantitative RT-PCR
We selected genes to be validated by quantitative RT-PCR
(qRT-PCR) in some specific functional classes: develop-
ment, differentiation and proliferation, signal transduc-
tion and trafficking, cell defense and finally gene
transcription and modification. We also selected genes
coding for secreted proteins as potential hits for biomar-
ker research. Tables 1 and 2 show the results of quantita-
tive RT-PCR validation (lines in bold) and the primers
used are described in table 3. Of the 29 genes tested, most
confirmed the variation observed in the microarrays
(83%). Five genes appeared to be modulated in the oppo-
site direction by qRT-PCR (AXL, IFNA4, DLG1, TNFRSF9
and SIN3A). Some discrepancies between the two tech-
niques may be due to technical artefacts even if the prim-
ers were designed within the microarray cDNA sequence.
For further analysis of gene modulation, we performed
time-course quantitative RT-PCR on several genes: AXL,
UBC, FBXL2 and SLC12A5 (figure 2). The results show
that modulation varies over time following various pro-
files: either diminishing at first, then increasing up to 24
h (AXL, SLC12A5), or being induced from 2 h (UBC), or
finally, early and continuous diminishing (FBXL2). For
genes displaying temporal modulation, down-fluctuation
quickly followed by up-regulation, as with AXL (figure 2),
a slight difference in the kinetics of different exposures
could explain the opposing results we found between
microarray and qRT-PCR ratios, because RNAs from dif-
ferent exposures were used to perform the microarray
experiments and qRT-PCR. These results, revealing an
oscillatory gene expression profile, suggest complex regu-
lation pathways in response to cobalt.
Hypoxia
Cobalt is known as a "hypoxia-simulating" agent[26] and
most of the literature therefore relates to this property.
Hypoxia-inducible factor (HIF-1) is a transcription factor
which acts as the main regulator of oxygen homeostasis
and the genes it induces have mostly been described [27].
We compared this list with our results to identify modula-
tions due to hypoxia. Strikingly, very poor overlap was
observed, as only 7 of the 85 modulated genes (8 %) in
our study matched HIF1 target genes. These 7 genes are:
aldolase A (ALDOA), glucose transporter 1 (SLC2A1),
glyceraldehyde 3-phosphate dehydrogenase (GAPD), lac-
tate dehydrogenase A (LDHA), proapoptotic factor
(BNIP3L), phosphoglycerate kinase 1 (PGK1) and trans-
ferrin receptor (TFRC), (table 1 and 2). Like HIF1 regu-
lated genes, they were all induced at 24 h by cobalt (except
TFRC  which was repressed at 30 min), therefore our
results agree with those already published and validate
our system relative to previous reports, since they repre-
ATP viability test on A549 cells exposed to cobalt Figure 1
ATP viability test on A549 cells exposed to cobalt. 
The cells were cultured for 24 h with increasing concentra-
tions of cobalt. Cell viability was determined by ATP Cell-
titer-Glow Luminescence Cell Viability Assay (Promega). 
Measurements were made on the Lumistar Galaxy (BMG) 
luminometer. The viability (V) was determined as the ATP 
ratio of treated cells versus control cells in %. The results are 
presented as mean ± SD (n = 4 to 8).BMC Genomics 2007, 8:147 http://www.biomedcentral.com/1471-2164/8/147
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Table 1: Functional classification and ratios of genes up-regulated (> 1.5-fold) by exposure to cobalt across all time points
Gene ID Gene Name Time (h) Microarray Ratio a qRT-PCR Ratio b
Development, differentiation and proliferation
DNAJA2 DnaJ (Hsp40) homolog, subfamily A, member 2 24 1.94 2.54 *
OAZ1 ornithine decarboxylase antizyme 1 24 1.68 2.26 *
PGF placental growth factor, vascular endothelial growth factor-related 
protein
0.5 1.50 1.37*
ST13 suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting 
protein)
24 1.52 1.59 *
TNFRSF9 tumor necrosis factor receptor superfamily, member 9 0.5 1.55 0.54 *
Signal transduction and trafficking
CTNNB1 catenin (cadherin-associated protein), beta 1, 88 kDa 24 1.73
DLG1 discs, large homolog 1 (Drosophila) 24 3.42 0.38 ***
GNB2L1 guanine nucleotide binding protein (G protein), beta polypeptide 2-like 
1
24 1.74 2.64 *
PLA2R1 phospholipase A2 receptor 1, 180 kDa 0.5 1.52
SCAMP1 secretory carrier membrane protein 1 24 4.00
SLC12A5 solute carrier family 12, (potassium-chloride transporter) member 5 0.5 1.58 1.69 ***
SLC25A6 solute carrier family 25 (mitochondrial carrier; adenine nucleotide 
translocator), member 6
24 1.89 3.12 ***
SLC2A1 solute carrier family 2 (facilitated glucose transporter), member 1 24 1.85 3.41 *
SLC6A11 solute carrier family 6 (neurotransmitter transporter, GABA), member 11 0.5 1.54
STXBP1 syntaxin binding protein 1 0.5 1.53
Cell defense
BNIP3L BCL2/adenovirus E1B 19 kDa interacting protein 3-like 24 1.89 3.30 *
CNIH cornichon homolog (Drosophila) 24 1.62
IFNA4 interferon, alpha 4 0.5 1.60 0.32 *
MGST1 microsomal glutathione S-transferase 1 24 3.80
SERPINC1 serine (or cysteine) proteinase inhibitor, clade C (antithrombin), 
member 1
24 1.59 5.02 *
Protein expression and turn-over
CANX calnexin 24 1.52
EEF1A1 eukaryotic translation elongation factor 1 alpha 1 24 1.63
EEF1G eukaryotic translation elongation factor 1 gamma 24 1.76
EIF4A1 eukaryotic translation initiation factor 4A, isoform 1 24 1.64
HSPA1A heat shock 70 kDa protein 1A 24 3.22
HSPCB heat shock 90 kDa protein 1, beta 24 2.21 2.51 *
KIAA1940 KIAA1940 protein 2 2.09
PPIA peptidylprolyl isomerase A (cyclophilin A) 24 1.59
RPL15 ribosomal protein L15 24 1.73
RPL35A ribosomal protein L35a 24 1.68
RPL36AL ribosomal protein L36a-like 24 1.55
SERPINH1 serine (or cysteine) proteinase inhibitor, clade H (heat shock protein 47), 
member 1,
24 1.61
SUI1 putative translation initiation factor 24 2.56
UBA52 ubiquitin A-52 residue ribosomal protein fusion product 1 4 2.22
UBB ubiquitin B 24 1.94
UBC ubiquitin C 24 5.58 8.17 *
WFDC2 WAP four-disulfide core domain 2 24 1.56
Gene transcription and modification
BHC80 BRAF35/HDAC2 complex (80 kDa) 24 1.76 1.85 *
HOXA9 homeo box A9 0.5 1.50 2.02 *
SDCCAG33 biglycan; serologically defined colon cancer antigen 33 0.5 1.51
Cell structure and mobility
SDC3 syndecan 3 (N-syndecan) 24 1.62
Metabolism and energy
AGPAT3 1-acylglycerol-3-phosphate O-acyltransferase 3 24 1.64
ALDOA aldolase A, fructose-bisphosphate 24 2.75
GAPD glyceraldehyde-3-phosphate dehydrogenase 24 3.01
LDHA lactate dehydrogenase A 24 1.66
OAT ornithine aminotransferase (gyrate atrophy) 24 3.15
PGK1 phosphoglycerate kinase 1 24 1.77BMC Genomics 2007, 8:147 http://www.biomedcentral.com/1471-2164/8/147
Page 5 of 13
(page number not for citation purposes)
SMAP1 stromal membrane-associated protein 1 24 1.65
TKT transketolase (Wernicke-Korsakoff syndrome) 24 1.86
Unknown function
GPM6A glycoprotein M6A 2 1.62
LOC115704 24 1.63
LTBP3 latent transforming growth factor beta binding protein 3 2 1.71 2.37 *
a: p value < 0.05 with 1.5 fold change.
b: validation with quantitative qRT-PCR (lines in bold) :
*: p value < 0.005, ** p value < 0.01, *** p value < 0.05.
Microarray p-values were calculated using a t-test statistical analysis (Benjamini-Hochberg FDR) on Genespring software. Pair Wise Fixed 
Reallocation Randomized Test was used to calculate qRT-PCR p values with REST software.
Table 1: Functional classification and ratios of genes up-regulated (> 1.5-fold) by exposure to cobalt across all time points (Continued)
sent an appropriate internal positive control. Recently,
two transcriptomic studies of hypoxia compared the
action of low oxygen with that of metal ions such as cobalt
or nickel on embryonic mouse fibrobasts [28] and human
liver carcinoma [29]. 21% and 28% of the genes respec-
tively were found to be modulated by both hypoxia and
cobalt. This shows that the toxic effect of cobalt is not lim-
ited to hypoxia. It should also be noted that nickel had an
action closer to that of low oxygen than cobalt, with 65%
common modulated genes [29]. Comparing these results
with ours showed that, apart from the hypoxia genes, we
had no overlap. This discrepancy might be due to differ-
ences between cell models, species and conditions of
exposure (one non-lethal dose of 0.1 mM cobalt for 24 h).
Stress response – apoptosis
The HSPCB gene coding for heat shock protein 90, was
induced by a factor of 2.2 at 24 h (table 1). HSP90 protein
plays a major role in the stress response by preventing irre-
versible protein aggregation. In our previous study of the
toxicogenomics of uranium [30], we noted that both
HSPCB gene and HSP90 protein were strongly repressed.
This protein can even be thought of as a metal "sensor",
since the HSPCB gene was also reported to be modulated
by other metals (Ni, As, Cr, Cd) [31]. However, we did not
see any change in the quantity of HSP90 in Western blot-
ting experiments (figure 3). This proteome/transcriptome
discordance can be explained by an increase in protein
turnover associated with gene induction, resulting in a
constant amount of protein being maintained in the cell.
Another explanation may be that, as Gerner observed for
apoptosis, HSP90 is aggregated and accumulates in the
insoluble fraction of the cytosol and is not collected dur-
ing protein extraction [32]. Two other genes described as
HSP mediators are also induced by cobalt: ST13  and
DNAJA2.
Ubiquitin is a key element in eliminating proteins via pro-
teasome because polyubiquitinylation is the recognition
signal for protein elimination [33,34]. The results show
that ubiquitin genes were up-regulated after 24 h of toxic
exposure (see table 1, UBB, ratio 1.94, UBC, ratio 5.6)
while UBC gene induction was observed in the kinetics
from 4 h with qRT-PCR (figure 2), showing that it is not
an early event in cell response. The Western blot revealed
protein ubiquitinylation, with the anti-ubiquitin anti-
body, shown by a smear at high molecular weight in the
cobalt extract, indicating an accumulation of ubiquiti-
nylated protein (figure 3). This demonstrates increased
turnover of proteins involved in defense against stress, or
the elimination of proteins partly damaged by the metal,
or the start of apoptosis.
Cobalt has been described as an apoptosis inducer [17]
and this is confirmed here by BAG1  repression and
BNIP3L induction (table 1 and 2).
Tumor suppressors – transcription factors
The protein encoded by MAZ (Myc-associated zinc finger
protein), is a transcription factor involved in both the ini-
tiation and termination of target gene transcription. It
binds zinc and can act as a tumor suppressor [35]. This
gene is repressed early at 2 h. Other cobalt-modulated
genes code for zinc-binding proteins involved in tran-
scription or DNA metabolism: BHC80 (BHC80 protein),
NT5E  (CD73) and SDCCAG33  (Teashirt homolog 1).
Cobalt ions have been shown to substitute for zinc in zinc
finger protein domains which control the transcription of
several genes and also in zinc-DNA repair proteins, inhib-
iting DNA repair [14,36,37].
DLG1 (disk large homolog 1) has been identified as a
tumor suppressor gene in drosophila, with its mutation
inducing the loss of cell polarity and neoplastic tissue
growth. This gene is highly conserved. The molecular
mechanism which regulates cell proliferation by DLG1 is
not well known but there are arguments for implicating
epithelial cell polarization in this regulation [38]. The
DLG1 (disk large homolog 1) gene was strongly repressed
in qRT-PCR. The anti-DLG1 antibody revealed clear
depletion of DLG1 protein in Co+ samples (figure 3). This
confirmed the results of the qRT-PCR.
Two tumor suppressors (MAZ and DLG1) were repressed
by cobalt, and in one case (DLG1), this repression was
also observed at protein level.BMC Genomics 2007, 8:147 http://www.biomedcentral.com/1471-2164/8/147
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Table 2: Functional classification and ratios of genes down-regulated (< 1.5 fold) by exposure to cobalt across all time points
Gene ID Gene Name Time (h) Microarray Ratio a qRT-PCR Ratio b
Development, differentiation and proliferation
NDRG4 NDRG family member 4 24 0.58 0.29 ***
SEZ6L seizure related 6 homolog (mouse)-like 4 0.62
Signal transduction and trafficking
ATP6V1A ATPase, H+ transporting, lysosomal 70 kDa, V1 subunit A 2 0.66
AXL AXL receptor tyrosine kinase 4 0.60 1.36 ***
GFRA2 GDNF family receptor alpha 2 0.5 0.63 0.09 *
ICAM1 intercellular adhesion molecule 1 (CD54), human rhinovirus receptor 2 0.60
IFNAR2 interferon (alpha, beta and omega) receptor 2 24 0.61 0.55 ***
MAPK10 mitogen-activated protein kinase 10 24 0.47 0.31 ***
S100A4 S100 calcium binding protein A4 2 0.64
TFRC transferrin receptor (p90, CD71) 0.5 0.50 0.65 *
Cell defense
BAG1 BCL2-associated athanogene 2 0.65 0.55 **
TNFSF6 tumor necrosis factor (ligand) superfamily, member 6 4 0.54
Protein expression and turn-over
CNDP2 CNDP dipeptidase 2 (metallopeptidase M20 family) 4 0.57
FBXL2 F-box and leucine-rich repeat protein 2 0.5 0.55 0.75 ****
TIMP2 tissue inhibitor of metalloproteinase 2 24 0.63 0.54 ***
Gene transcription and modification
MAZ MYC-associated zinc finger protein (purine-binding transcription factor) 2 0.28 0.59 **
NT5E 5'-nucleotidase, ecto (CD73) 24 0.50
PAI-RBP1 PAI-1 mRNA-binding protein 2 0.62
SFRS1 splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor) 0.5 0.52
SIN3A SIN3 homolog A, transcriptional regulator (yeast) 24 0.63 2.21 *
Cell structure and mobility
FAT2 FAT tumor suppressor homolog 2 (Drosophila) 4 0.56
TUBB2 tubulin, beta, 2 4 0.62
VIL2 villin 2 (ezrin) 0.5 0.64
Metabolism and energy
AKR1C3 aldo-keto reductase family 1, member C3 24 0.53
ALDH1A1 aldehyde dehydrogenase 1 family, member A1 24 0.60
GLCE glucuronyl C5-epimerase 0.5 0.46
GPD2 glycerol-3-phosphate dehydrogenase 2 (mitochondrial) 4 0.55
MTHFS 5,10-methenyltetrahydrofolate synthetase 2 0.52
Unknown function
C20orf30 chromosome 20 open reading frame 30 2 0.48
C20orf30 chromosome 20 open reading frame 30 24 0.60
FLJ12806 hypothetical protein FLJ12806 0.5 0.64
KIAA158
2
KIAA1582 protein 24 0.58
a: p value < 0.05 with 1.5 fold change.
b: validation with quantitative qRT-PCR (lines in bold) :
*: p value < 0.005, ** p value < 0.01, *** p value < 0.05, **** p value < 0.1.
Microarray p-values were calculated using a t-test statistical analysis (Benjamini-Hochberg FDR) on Genespring software. Pair Wise Fixed 
Reallocation Randomized Test was used to calculate qRT-PCR p values with REST software.
We noted the modulation of three genes related to MYC,
a key element in oncogenic response (table 1 and 2). The
first, SIN3A, known as an MYC suppressor, is induced by
cobalt. The two others: NDRG4, a gene negatively regu-
lated by MYC and MAZ, a MYC transcription inhibitor, are
down-regulated by cobalt. These results are not clear
regarding MYC up- or down-regulation, but MYC regula-
tion pathways are complex. These results led us to hypoth-
esize that MYC  might be modulated by cobalt, so we
tested MYC temporal modulation with qRT-PCR. Interest-
ingly, we noted significant MYC inhibition from 30 min
to 24 h (figure 2) indicating that cobalt modulates regula-
tion pathways controlling or controlled by MYC. Liu has
recently shown that MYC is involved in the carcinogenic
response of mouse liver to arsenic, another toxic metal
[39].BMC Genomics 2007, 8:147 http://www.biomedcentral.com/1471-2164/8/147
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The AXL gene is positively modulated. Members of the
AXL/UFO family of tyrosine kinases are prone to tran-
scriptional regulation and perform various functions
including regulation of cell adhesion, migration, phago-
cytosis, and survival. The biological consequences of AXL
activation are complex. AXL was initially identified as a
transforming gene product, and AXL expression is indeed
up-regulated in human tumors [40,41].
Concerning the potential effects of cobalt on cancer devel-
opment, it will be interesting to carry out further studies
of the mechanisms by which cobalt induces these
responses. These genes have never been linked to cobalt
effects before.
Transporters
Two cobalt transporters are described in yeast: COT1 and
COT2 [42]. Eleven cobalt-tolerant mutants were obtained
with a common COT2  mutation, suggesting that it is
involved in cobalt uptake [43]. The mutants were resistant
to cobalt toxicity and cobalt was not incorporated in yeast
cells. The human homolog of COT2, FBXL2, was strongly
repressed in our study as early as 2 h and with a ratio of
0.1 at 24 h; this is the strongest inhibition observed in
time-course qRT-PCR analysis (figure 2). FBXL2 function
is not very well described, but it is potentially involved in
ubiquitinylation. Conklin's observations on the yeast
homolog of FBXL2 [43] and our results, lead us to suggest
that FBXL2 gene repression could be a cellular defense
mechanism and this protein might be associated with
cobalt uptake in humans.
The product of the COT1 gene is involved in the uptake of
cobalt ions [44]. COT1, has a human homolog in ZNT1,
coding for Zinc transporter 1 protein, probably involved
in zinc transport out of the cell. ZNT1, not spotted on the
microarray, was also tested in kinetics with qRT-PCR and
was found to be slightly modulated with a biphasic
response; first down- then up-regulated (figure 2).
The SLC12A5 gene, coding for an integral membrane K-Cl
cotransporter, was repressed at 4 h then strongly increased
at 24 h (qRT-PCR ratio : 4.3). The three genes, FBXL2,
ZNT1 and SLC12A5, are therefore appropriate candidates
for research into cobalt transport proteins in human cells
and will be studied further using targeted biological
approaches.
Potential biomarkers and secreted proteins
Biological monitoring of exposure to cobalt is mainly
based on its concentration in urine. This method may be
inadequate for two reasons. Firstly, measuring the quan-
tity of excreted metal (exposure marker) does not neces-
sarily reflect organ damage, which varies from one person
to another. Furthermore, depending on the chemical
form, excretion does not necessarily reflect the concentra-
tion of metal in the body; indeed, certain forms are elim-
inated in several phases; only 40% of cobalt oxides
inhaled are excreted within 72 h [45]. In this context, only
an effective biomarker could evaluate the damage and
provide a valuable tool for monitoring occupational con-
tamination in the event of accidental acute exposure or
chronic exposure. We selected nine modulated genes cod-
ing for secreted proteins: ICAM1  (CD54),  SERPIN C1
(antithrombin-III),  IFNA4  (alpha-4 interferon), TFRC
(transferrin receptor), PLA2R1  (phospholipase receptor
A2), TNFSF6 (FAS ligand), WFDC2 (WAP four-disulfide
core domain protein 2), LTBP3  (latent transforming
growth factor beta binding protein 3) and TIMP2 (tissue
inhibitor of metalloproteinase 2). To further evaluate the
interest of these genes, we checked the secretion modula-
tion of the corresponding proteins. A549 cells were
exposed to cobalt in a dose-response manner, to 0.2, 1
and 2 mM, and the supernatants analysed using available
immunoassays. The levels of FAS ligand, WFDC2 [46],
ICAM1, antithrombin-III, alpha-4 interferon, and soluble
transferrin receptor were found to be invariant or below
the kit detection limit. These results indicate that most of
these immunoassays were not sensitive enough to detect
faint modulations. TIMP2 protein (tissue inhibitor of
metalloproteinase 2) was measured using ELISA and we
confirmed the modulation recorded at gene level (micro-
array ratio: 0.63, qRT-PCR ratio: 0.69). A strong decrease
in TIMP2 supernatant concentration was noted at 1 or 2
mM of cobalt (figure 4). The changes in TIMP2 levels in
cell supernatants between cobalt and the control were -
5% for 0.2 mM, -57% for 1 mM and -72% for 2 mM. The
reason for this reduction in TIMP2 can be explained as a
consequence of cobalt exposure. Matrix metalloprotein-
ases (MMPs) are a family of endopeptidases that can
degrade all the components of the extracellular matrix
[47]. Endogenous protease inhibitors, known as tissue
inhibitors of metalloproteinase (TIMP), provide critical
extracellular regulation of MMP proteolytic activities
[48,49], regulating tumor growth, progression, and angio-
genesis in a variety of experimental cancer models and
human malignancies. TIMP2 mRNA is described as being
suppressed by hypoxia in endothelial cells [50]. Exposure
of cells to cobalt up-regulates indirectly hypoxia-inducible
genes by a mechanism which has recently been explained
[51]. Therefore, TIMP-2 down-regulation might be a con-
sequence of cobalt-simulated hypoxia. Down-regulation
of TIMP2 mediated by ROS production has been observed
by Rezzani in rat cardiac tissue exposed to cyclosporin
[52]. Since it is known that cobalt triggers ROS production
[16], TIMP2 modulation by cobalt could also be
explained by this pathway.
TIMP2 protein modulation in cobalt-exposed cell super-
natant corroborated the gene down-regulation observedBMC Genomics 2007, 8:147 http://www.biomedcentral.com/1471-2164/8/147
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Table 3: List of primers used in qRT- PCR
Gene ID Gene Name GenBank ID Forward primer Reverse primer Amplicon (bp)
AXL AXL receptor tyrosine 
kinase
NM_001699 GACCGGCCAAGTTTTACAGA ATAACCTCCACCCTCATCCA 117
BAG1 BCL2-associated 
athanogene
NM_004323 GCAGCAGTGAACCAGTTGTC CGGTGTTTCCATTTCCTTCA 119
BHC80 BRAF35/HDAC2 complex 
(80 kDa)
NM_016621 CCGAGCCGTTTGTTTAGGTA CACTGGGGTTGGTGAAATCT 117
BNIP3L BCL2/adenovirus E1B 19 
kDa interacting protein 3-
like
NM_020221 ATGTTTGGCTTTGGGGCTA CTTCACAGGTCACACGCATT 109
DLG1 discs, large homolog 1 
(Drosophila)
NM_004087 CAGCCAGATACTCCCCAGTT TGAGCCACGATGAAGAACAA 89
DNAJA2 DnaJ (Hsp40) homolog, 
subfamily A, member 2
NM_005880 CCAGGGTGTGTTCGTGTAGTT TGGGTTGATCCAGTTGTTTTC 120
FBXL2 F-box and leucine-rich 
repeat protein 2
NM_012157 CAGAACTGCCGAAACATTGA CACACAGGAGGTCAGATCCA 123
FIGF c-fos induced growth 
factor (vascular 
endothelial growth factor 
D)
NM_004469 GAACACCAGCACCTCGTACA TGGCAAGCACTTACAACCTG 118
GFRA2 GDNF family receptor 
alpha 2
NM_001495 GAGACACACGGTCACTGGAA TCGAGGACGAGAGACTGGAG 126
GNB2L1 guanine nucleotide binding 
protein (G protein), beta 
polypeptide 2-like 1
NM_006098 GGTGTCTTGTGTCCGCTTCT CAATGTGGTTGGTCTCAGC 119
HOXA9 homeo box A9 NM_152739 CACCAGACGAACAGTGAGGA ACTCCGTTACAATCAGCATTCA 111
HSPCB Heat shock protein HSP 
90-beta
NM_007355 GGAGAGGAGGAGGTGGAGAC GAGGGTTGGGGATGATGTC 217
IFNA4 interferon, alpha 4 NM_021268 GAAGAAATACAGCCCTTGTGC TGAACCAGTTTTCAATCCTTCC 114
IFNAR2 interferon (alpha, beta and 
omega) receptor 2
NM_000874 GTCTCGCTAAGGGCTGGAAT AGGCAGGACGACTGTTTGAG 94
LTBP3 latent transforming 
growth factor beta binding 
protein 3
NM_021070 CCAGGGCTACAAGAGGCTTA GGCAGACACAGCGATAGGAG 119
MAPK10 mitogen-activated protein 
kinase 10
NM_002753 CTTCCCAGATTCCCTCTTCC GTAAGGCGTCGTCCACTGAT 128
MAZ MYC-associated zinc 
finger protein (purine-
binding transcription 
factor)
NM_002383 CGGATCACCTCAACAGTCAC ATGGCACTTTCTCCTCGTGT 135
MYC v-myc myelocytomatosis 
viral oncogene homolog 
(avian)(MYC)
NM_002467 AAAGGCCCCCAAGGTAGTTA TTTCCGCAACAAGTCCTCTT 103
NDRG4 NDRG family member 4 NM_020465 ATGCTTTCCATCCACTCACC TTCACTGCTCTCTCCCGTTT 115
OAZ1 ornithine decarboxylase 
antizyme 1
NM_004152 GAGCCGACCATGTCTTCATT CCCGGTCTCACAATCTCAAA 100
PGF placental growth factor, 
vascular endothelial 
growth factor-related 
protein
NM_002632 ACCCCTTGGAGGAGAGAGAC GCATTCAGCAGGGAAACAGT 119
SERPINC1 serine (or cysteine) 
proteinase inhibitor, clade 
C (antithrombin), member 
1
NM_000488 CAATCGCCTTTTTGGAGACA TGGACACCCATTTGTTGATG 146
SIN3A SIN3 homolog A, 
transcriptional regulator 
(yeast)
NM_015477 CTCCCAACTGCAAGCACATA TCCCAACGAGATTGTCACTG 115
SLC12A5 solute carrier family 12, 
(potassium-chloride 
transporter) member 5
NM_020708 CAAGGGTCCAACTTTTCCTG GCCTCTCGGTTTCTTCCTCT 152
SLC25A6 solute carrier family 25 
(mitochondrial carrier; 
adenine nucleotide 
translocator), member 6
NM_001636 CTGTTTTGCACAGCCGAGTA TTTTGACCTCTGCGTCCTCT 87BMC Genomics 2007, 8:147 http://www.biomedcentral.com/1471-2164/8/147
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on the microarrays and with qRT-PCR. TIMP2 modula-
tion has never been associated with metal stress. This
result is innovative and will be studied further in the bio-
logical fluids of rats exposed to different chemical forms
of cobalt by inhalation.
Conclusion
This study provides the first toxicogenomic analysis of
human lung cell response to acute cobalt exposure. We
have confirmed that genes involved in the cobalt hypoxia
response and apoptosis are modulated. We have also
revealed genes linked to heat shock response and proteas-
ome function that have already been described in other
metal stress responses. Newly identified genes linked to
cobalt acute toxicity include potential cobalt carriers
(FBXL2, ZNT1, SLC12A5) and tumor suppressors or tran-
scription factors (MAZ, DLG1, MYC, AXL). Some of these
genes provide new hypotheses for elucidating the mecha-
nisms of cobalt intracellular chemical toxicity. Targeted
biological approaches might confirm their biochemical
role in the cobalt response.
Regarding biomarkers, we have highlighted the down-reg-
ulation of TIMP2, a gene coding for a secreted protein.
TIMP2 modulation was confirmed at protein level, in a
dose-dependent manner, in the supernatant of exposed
A549 cells. TIMP2 provides a putative biomarker of cobalt
toxicity that will be further studied on animal models.
Methods
Cell culture
The human type II epithelial cell line A549 from ATCC,
was cultured as described previously [53]. At midlog
phase, a medium without FCS, containing cobalt (CoCl2,
Sigma) or not, was added for 24 hours. A CoCl2 stock
solution (1 M in MilliQ water) was prepared extempora-
neously, filtered through a sterile 0.22 μm membrane and
then diluted in the cell culture medium (final concentra-
tion 2 mM). After 30 mn, 2 h, 4 h or 24 h, the cells were
harvested with trypsin and washed in PBS containing 1
mM EDTA. Culture supernatants for ELISA and cells for
Western blot confirmations were collected after 24 h of
exposure.
Cytotoxicity studies
Cobalt cytotoxicity was determined by measuring the
intracellular ATP after 24 h using the Promega Celltiter-
GlowTM Luminescence Cell Viability Assay (four to eight
replicates per concentration). The viability rate was deter-
mined as the ratio between the ATP in treated cells and
control cells. Cobalt concentration in cell pellets was
measured using flame atomic absorption spectroscopy
(FAAS, CERECO laboratory, Nimes, France).
RNA extraction
Total RNA was isolated using the Quiagen RNeasy mini-
prep kit according to the manufacturer's instructions.
mRNAs were prepared using the Oligotex mRNA Quiagen
kit, the purification process being repeated once to elimi-
nate any contamination. RNA concentration was deter-
mined by OD measurement (260 nm/280 nm), purity
and integrity were assessed using an Agilent 2100 Bioana-
lyser.
Microarrays and data analysis
Microarrays were obtained from the Service de Genom-
ique Fonctionnelle (CEA, Evry, France). Two types of DNA
collections were used for preparing the cDNA arrays: a col-
lection of 5760 full length cDNA clones from the human
infant brain 1NIB library, kindly provided by Genethon,
and a collection of 2304 human PCR products (400–600
bp) corresponding to specific key-words selected by direct
SLC2A1 solute carrier family 2 
(facilitated glucose 
transporter), member 1
NM_006516 GTGGAGACTAAGCCCTGTCG CATAGCCACCTCCTGGGATA 128
ST13 suppression of 
tumorigenicity 13 (colon 
carcinoma) (Hsp70 
interacting protein)
NM_003932 AGGCAGACGAACCATCAAGT TCCGTTATCTCCGCATTTTC 115
TFRC transferrin receptor (p90, 
CD71)
NM_003234 CGCTGGTCAGTTCGTGATTA TCAGGCCCATTTCCTTTATG 134
TIMP2 tissue inhibitor of 
metalloproteinase 2
NM_003255 TTCATTCGTCTCCCGTCTTT ACCAACGTGTGTGGATCAAA 113
TNFRSF9 tumor necrosis factor 
receptor superfamily, 
member 9
NM_001561 AGGGCTGTTGGGACTTTCTT GGATGGTGTTCTTGCTTTTGA 83
TUBA3 tubulin, alpha 3 NM_006009 CCTACAACTCCATCCTCACCA GTCAACATTTCAGGGCTCCA 203
UBC ubiquitin C NM_021009 GGAACAGGCGAGGAAAAGTA AACAAGAACTGCGACCCAAA 146
ZNT1 solute carrier family 30 
(zinc transporter), 
member 1
NM_021194 ACCCAGAAAACCCCAGAAGT CACTGAACCCAAGGCATCTC 158
Table 3: List of primers used in qRT- PCR (Continued)BMC Genomics 2007, 8:147 http://www.biomedcentral.com/1471-2164/8/147
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query in the Unigene database. A complete description of
the microarrays used in this study, including the protocols
for slide production, has been submitted to the GEO data-
base [24] under accession number GPL4263.
For each microarray experiment, 20 μg of total RNA were
reverse transcripted and indirectly labelled using the Fair-
Play Microarray Labelling Kit (Stratagene). Amino reactive
Cy3- and Cy5- dyes (Cy™ Dye Post-Labelling Reactive Dye
Time-course qRT-PCR analysis Figure 2
Time-course qRT-PCR analysis. The temporal expression pattern of genes regulated by cobalt was analysed by qRT-PCR 
in sextuplets for each time point. Mean results are given in Log2 ratios ± SD. *: significant modulation calculated by pairwise 
testing with p < 0.05BMC Genomics 2007, 8:147 http://www.biomedcentral.com/1471-2164/8/147
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Pack, Amersham) were then chemically bound to cobalt
and control cDNA respectively. Reverse labelling (or dye-
swap) was performed for each experiment. Microarrays
were pre-treated for 20 min with an N-methyl-pyrrolidi-
none solution containing 20 g/L succinic anhydride and
20 mM sodium borate, pH 8, immersed quickly in etha-
nol and dried by centrifugation for 6 min at 500 rpm. Fol-
lowing a quick rinse in RNase-free water, the slides were
prehybridized in 30 ml 5X SSC, 1% SDS, 1% BSA (w/v) at
50°C for 40 min. The microarrays were then rinsed in
RNAse-free water, immersed quickly in isopropanol and
dried by centrifugation for 6 min at 500 rpm. The hybrid-
ization solution was prepared using 100 μl formamide, 10
μl SDS 10% and 30 μl RNase-free water. Labelled cDNA
was solubilized in 17.5 μl of this solution plus 7.5 μl of 20
× SSPE and heat-denatured. Hybridization was performed
overnight at 42°C. The microarrays were quickly rinsed in
0.1 × SSC, 0.01% SDS, washed twice for 10 min in 0.01 ×
SSC, then dried quickly in a stream of nitrogen and
scanned with GenePix 4000B (Axon Instrument Inc., For-
ster City, CA). Cy3 and Cy5 spot fluorescence intensities
were quantified after local subtraction of background
using Genepix Pro 4.0 software (Axon Instrument Inc.).
For each time point the result files were submitted to
GeneSpring software 6.2 (Agilent Technologies) as fol-
lows. The data were first converted to take into account
the results of the dyeswap reverse labelling, then normal-
ized using the Lowess method, applying robust locally-
weighted regression to smooth the intensity-dependence
of the log ratios. The normalized data were then filtered
on a quality test basis. This involved selecting spots
detected on at least half of the microarrays with at least
70% pixels above threshold intensity (set to the median
background plus two standard deviations).
From these remaining spots, we selected those with fluo-
rescence ratios (representing cobalt-treated cells versus
control) above 1.5 fold with p-value < 0.05 using a t-test
statistical analysis on Genespring software and perform-
ing a Benjamini and Hochberg false discovery rate multi-
ple testing correction.
Quantitative real-time polymerase chain reaction (qRT-
PCR)
Specific primers were designed with Primer3 [54] using
cDNA sequences spotted on microarrays, and amplicons
were controlled using Mfold [55]. The list of primers is
given in table 3. Before differential analysis, good primer
efficiency (80% -120 %) was checked as a mandatory test.
One μg of total RNA (for 30 min, 2 h and 4 h) or 50 ng of
mRNA (for 24 h) were reverse transcribed with oligo dT
(12–18) using Omniscript reverse transcriptase (Qiagen)
following the manufacturer's instructions. cDNA was
diluted at least 10-fold with DNase-free water to 10 ng/μL.
PCR was performed on 15 μl using a DyNAmoTM HS
SYBR Green qPCR Kit (Finnzymes) on a VWR DNA
Engine Opticon® 2 system. The amplification program
consisted of 1 cycle at 95°C with 10 min-hold followed by
40 cycles at 95°C with 15 sec-hold, 60°C with 1 min-
hold, and a reading step at 60°C for 1 sec. Amplification
was followed by melting curve analysis between 65°C and
95°C. RNA was used as a negative template for the
absence of residual genomic DNA and a negative control
without cDNA was used to control overall specificity.
House- keeping genes, which are generally used as refer-
ence genes, are often modulated by stress. For example,
GAPDH is strongly induced by cobalt (ratio 3). To find an
invariant gene at each time point, several candidates were
selected for their invariance from all the microarray data,
and tested as invariant genes in qRT-PCR. FIGF (c- fos
induced growth factor) was selected for time points 0.5 h,
2 h and 4 h. For samples at 24 h, mRNA had to be purified
TIMP2 ELISA Figure 4
TIMP2 ELISA. Concentrations of TIMP2 in supernatants 
were determined by ELISA following treatment of A549 cells 
with cobalt over 24 h. The changes in level of TIMP2 in cell 
supernatants between cobalt and the control were -5% for 
0.2 mM, -57% for 1 mM and -72% for 2 mM (n = 2).
Western blot confirmation Figure 3
Western blot confirmation. Western blot analyses were 
performed on A549 extracts following exposure to 2 mM 
cobalt for 24 h. Treated (Co+) and control (Co-) extracts 
were probed with anti-ubiquitin, anti-DLG1, or anti-HSP90 
antibodies. An anti-actin antibody was used as a control.BMC Genomics 2007, 8:147 http://www.biomedcentral.com/1471-2164/8/147
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from total RNA to detect TUBA3 as an invariant reference
gene. Differential analysis was performed on cDNA tem-
plates obtained from cobalt-treated or untreated cells in
sextuplets for each gene, in the same way as for the refer-
ence gene (5 ng for cDNA from total RNA or 0.1 ng for
cDNA from mRNA). The results were processed using
REST-MCS software [56] and tested for significance using
a Pair Wise Fixed Reallocation Randomized Test by calcu-
lating a p value. Modulation was considered to be signifi-
cant when p calculated by REST software was < 0.05.
Western blot
Western blots were performed as previously described
[53] after 24 h of cobalt exposure. Cells were lysed with 7
M urea, 2 M thiourea, 4% CHAPS, 20 mM spermine base,
anti proteases (Roche cocktail), 40 mM DTT or 50 mM
Tris-HCl, NaCl 150 mM ph7.5, 20 mM spermine base,
anti proteases, 0.5% NP40 and 1% DOC. 10 to 50 μg of
proteins were loaded onto a 4–12% or 12% NuPAGE gel
in a MOPS or MES buffer (Invitrogen). Primary antibodies
were: mouse monoclonal anti-DLG1 (sc-9961, 1/100,
Santa Cruz), rabbit polyclonal anti-hsp90β (Ab1, 1/1666,
NeoMarkers), mouse monoclonal anti-βactin (AC-15, 1/
2000, Sigma), or mouse monoclonal anti-ubiquitin
(P4D1, 1/400, Santa Cruz). A VECTASTAIN ABC kit (Vec-
tor laboratories) or a goat anti-mouse IgG coupled to HRP
(1/10000, Novagen) was used for detection.
Immunoassays
Immunoassays were performed on culture supernatants
from cells exposed to various concentrations of cobalt
over a 24 h period. The supernatants were tested crude or
at 10 fold concentration. TIMP2 and FASL proteins were
detected using ELISA kits (Raybiotech and R&D systems
respectively) according to the manufacturer's instructions.
The WFDC2 protein, was analysed in Dr Hellström's lab-
oratory because they developed the WFDC2 ELISA [46].
Other immunoassays were performed by the CERBA lab-
oratory (Cergy Pontoise, France).
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